Oral immunization of mice with a glycoconjugate vaccine containing the O157 antigen ofEscherichia coliO157:H7 admixed with cholera toxin fails to elicit protection against subsequent colonization by the pathogen
- 1 March 2000
- journal article
- Published by Canadian Science Publishing in Canadian Journal of Microbiology
- Vol. 46 (3) , 283-290
- https://doi.org/10.1139/w99-142
Abstract
It has been postulated that a humoral immune response directed against the O157 antigen of Escherichia coli O157:H7, and expressed in the intestine, might afford protection from colonization and consequent infection by this enteric pathogen. The present study was conducted to determine whether such an immune response can be experimentally generated in mice. To this end, mice were orally immunized with a glycoconjugate vaccine consisting of horse serum albumin and the O157 polysaccharide admixed with the mucosal adjuvant, cholera toxin. Mice consistently developed robust local and systemic immune responses to the cholera toxin adjuvant, but were far from uniformly reactive to the test vaccine. Moreover, vaccinated mice were as susceptible to transient intestinal colonization following challenge with an isolate of E. coli O157:H7 as unvaccinated control mice. These results indicate that this vaccination approach is unlikely to be straightforward in target bovine or human hosts.Key words: Escherichia coli O157:H7, glycoconjugate vaccine, mucosal immunity, mice.Keywords
This publication has 9 references indexed in Scilit:
- Immunosuppression by a corticosteroid fails to exacerbate Helicobacter pylori infection in a mouse model of gastric colonizationCanadian Journal of Microbiology, 1999
- Salmonella landau as a live vaccine against Escherichia coli O157:H7 investigated in a mouse model of intestinal colonizationCanadian Journal of Microbiology, 1999
- Susceptibility of three strains of conventional adult mice to intestinal colonization by an isolate of Escherichia coli O157:H7Canadian Journal of Microbiology, 1998
- Investigational Vaccine forEscherichia coliO157: Phase 1 Study of O157 O‐SpecificPolysaccharide‐Pseudomonas aeruginosaRecombinant Exoprotein A Conjugates in AdultsThe Journal of Infectious Diseases, 1998
- Escherichia coli O157: H7 Infection in HumansAnnals of Internal Medicine, 1995
- Development of Oral Vaccines to Stimulate Mucosal and Systemic Immunity: Barriers and Novel StrategiesClinical Immunology and Immunopathology, 1995
- Effective Mucosal Immunity: Current Concepts for Vaccine Delivery and Immune Response AnalysisInternational Journal of Technology Assessment in Health Care, 1994
- Selective Transport of IgAGastroenterology Clinics of North America, 1991
- Expression of glycolipid receptors to Shiga-like toxin on human B lymphocytes: a mechanism for the failure of long-lived antibody response to dysenteric diseaseInternational Immunology, 1990